Johnson & Johnson (NYSE:JNJ)

141.85
Delayed Data
As of 4:00pm ET
 -2.39 / -1.66%
Today’s Change
120.11
Today|||52-Week Range
148.99
+9.92%
Year-to-Date
Pacira Gets EMA Acceptance for Pain Management Drug Exparel
6:55pm / Zacks.comZAK - Paid Partner Content
The Value of Best-in-Class Management
Jun 20 / GuruFocus NewsGURU - Paid Partner Content
3 Top-Performing Large-Cap Stocks
12:55pm / GuruFocus NewsGURU - Paid Partner Content
Big Drugmakers That May Tread the M&A Path After Pfizer
Jun 19 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
Jun 25 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson to Host Investor Conference Call on Second-Quarter Results
Jun 18 / PR NewswirePRN - Paid Partner Content
The 10 Biggest Biotech Stocks
Jun 25 / MotleyFool.comFOO - Paid Partner Content
Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know
Jun 17 / Zacks.comZAK - Paid Partner Content
3 Top Healthcare Stocks to Buy Right Now
Jun 24 / MotleyFool.comFOO - Paid Partner Content
J&J's (JNJ) Tremfya Meets Goal in Psoriatic Arthritis Study
Jun 17 / Zacks.comZAK - Paid Partner Content
3 Excellent Dividend Aristocrats You Can Buy Right Now
Jun 24 / MotleyFool.comFOO - Paid Partner Content
5 Biggest Blockbuster Drugs of the Future
Jun 15 / MotleyFool.comFOO - Paid Partner Content
Dow 30 Stock Roundup: Boeing's $6.5B Air Force Contract, Pfizer to Buy Array BioPharm...
Jun 21 / Zacks.comZAK - Paid Partner Content
Medidata (MDSO) to be Acquired by Dassault for $5.8 Billion
Jun 14 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson (JNJ) is a Top Dividend Stock Right Now: Should You Buy?
Jun 21 / Zacks.comZAK - Paid Partner Content
Johnson & Johnson Releases 2018 Health for Humanity Report
Jun 05 / PR NewswirePRN - Paid Partner Content
Sphera Funds Management Ltd. Buys Johnson & Johnson, Novo Nordisk A/S, Bristol-Myers ...
Jun 20 / GuruFocus NewsGURU - Paid Partner Content
MyPhillyLawyer Helps Secure $80 Million Victory for Transvaginal Mesh Patient
Jun 03 / PR NewswirePRN - Paid Partner Content